Who owns KAZIA THERAPEUTICS LTD SPONSORED ADS?
- Ticker: KZIA
- CUSIP Number: 48669g303
Tip: Access positions for across all investors
Analyze quarterly positions in Kazia Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Kazia Therapeutics stock
Who bought or sold KAZIA THERAPEUTICS LTD SPONSORED ADS this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Stonepine Capital Management | 460k | $3.2M | 100% | Dec 2025 |
|
| Bleichroeder | 400k | $2.8M | 100% | Dec 2025 |
|
| Velan Capital Investment Management | 300k | $2.1M | 100% | Dec 2025 |
|
| Point72 Asset Management | 200k | $1.5M | 0% | Mar 2026 |
|
| Balyasny Asset Management | 193k | $1.4M | 100% | Mar 2026 |
|
| Putnam Fl Investment Management | 143k | $1.1M | 100% | Mar 2026 |
|
| Sequoia Financial Advisors | 60k | $446k | 100% | Mar 2026 |
|
| Westside Investment Management | 50k | $375k | 63% | Mar 2026 |
|
| Royal Bank of Canada | 34k | $255k | 100% | Mar 2026 |
|
| Barclays | 24k | $165k | 0% | Dec 2025 |
|
| UBS Group | 14k | $98k | 7120% | Mar 2026 |
|
| Rockefeller Capital Management | 13k | $95k | 19% | Mar 2026 |
|
| Engineers Gate Manager | 10k | $72k | 100% | Dec 2025 |
|
| FNY Investment Advisers | 10k | $74k | 33% | Mar 2026 |
|
| GAMMA Investing | 1.6k | $12k | 576% | Mar 2026 |
|
| Rhumbline Advisers | 1.4k | $10k | -10% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 1.1k | $8.0k | 100% | Mar 2026 |
|
| Morgan Stanley | 1.0k | $7.4k | 0% | Mar 2026 |
|
| Advisor Group Holdings | 10.00 | $68.000000 | 0% | Dec 2025 |
|
| Hanson McClain Advisors | 1.00 | $7.000000 | 0% | Dec 2025 |
|
| Dauntless Investment Group | 1.00 | $7.000000 | -100% | Dec 2025 |
|
Who sold out of Kazia Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Alyeska Investment Group | Dec 2025 | 738k | $5.1M |
| Empery Asset Management | Dec 2025 | 170k | $1.2M |
| Corsair Capital Management | Dec 2025 | 70k | $470k |
| SRS Capital Advisors | Dec 2025 | 200.00 | $1.4k |